Matt Cwiklinski

Matt Cwiklinski joined DavosPharma in 2019. His responsibilities include developing new business in Southern California and the Midwest. Prior to joining Davos, he spent 12 years developing new customers for Olon Ricerca (formerly Ricerca Biosciences), Apiscent Labs, LLC (formerly Fontarome Chemical), and Cambridge Major Laboratories (now part of Sterling Pharma). During these years, he developed relationships with emerging biotech to large multi-national pharma clients to bring their APIs from concept to commercial. Prior to Business Development, Matt spent 10 years performing process development, scale up, and cGMP manufacturing with Cambridge Major Laboratories. Matt received his B.S. in Chemistry from the University of Minnesota – Twin Cities.